Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thorsten Zenz

Showing results (141-150 of 183) with videos related to

Pageof 19
Sort By:
The Lancet. Oncology|September 13, 2024
Atezolizumab, venetoclax, and obinutuzumab combination in Richter transformation diffuse large B-cell lymphoma (MOLTO): a multicentre, single-arm, phase 2 trialAlessandra Tedeschi, Anna Maria Frustaci, Adalgisa Condoluci, et al.
Nature Communications|July 9, 2020
IgCaller for reconstructing immunoglobulin gene rearrangements and oncogenic translocations from whole-genome sequencing in lymphoid neoplasmsFerran Nadeu, Rut Mas-de-Les-Valls, Alba Navarro, et al.
Haematologica|August 2, 2014
MDM2 promotor polymorphism and disease characteristics in chronic lymphocytic leukemia: results of an individual patient data-based meta-analysisAxel Benner, Larry Mansouri, Davide Rossi, et al.
Mabs|December 18, 2014
Inhibitors of SRC kinases impair antitumor activity of anti-CD20 monoclonal antibodiesMagdalena Winiarska, Kamil Bojarczuk, Beata Pyrzynska, et al.
Leukemia|March 27, 2019
Short telomeres are associated with inferior outcome, genomic complexity, and clonal evolution in chronic lymphocytic leukemiaBilly Michael Chelliah Jebaraj, Eugen Tausch, Dan A Landau, et al.
Nature Communications|March 10, 2026
Single-cell genomics highlight MYC-associated metabolic activation and altered cell interactions in T-prolymphocytic leukemia progressionLinus Wahnschaffe, Dennis Jungherz, Tony A Müller, et al.
Blood|January 27, 2025
IAP dependency of T-cell prolymphocytic leukemia identified by high-throughput drug screeningMarcel Fabian Pohly, Kerstin Putzker, Sebastian Scheinost, et al.
Haematologica|July 11, 2019
HIF-1α is over-expressed in leukemic cells from <i>TP53</i>-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemiaValentina Griggio, Candida Vitale, Maria Todaro, et al.
Blood|August 13, 2017
Genomic analysis of hairy cell leukemia identifies novel recurrent genetic alterationsBenjamin H Durham, Bartlomiej Getta, Sascha Dietrich, et al.
Nature Genetics|January 19, 2016
DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemiaChristopher C Oakes, Marc Seifert, Yassen Assenov, et al.
Pageof 19

Showing results (141-150 of 183) with videos related to

Sort By:
Pageof 19
The Lancet. Oncology|September 13, 2024
Atezolizumab, venetoclax, and obinutuzumab combination in Richter transformation diffuse large B-cell lymphoma (MOLTO): a multicentre, single-arm, phase 2 trialAlessandra Tedeschi, Anna Maria Frustaci, Adalgisa Condoluci, et al.
Nature Communications|July 9, 2020
IgCaller for reconstructing immunoglobulin gene rearrangements and oncogenic translocations from whole-genome sequencing in lymphoid neoplasmsFerran Nadeu, Rut Mas-de-Les-Valls, Alba Navarro, et al.
Haematologica|August 2, 2014
MDM2 promotor polymorphism and disease characteristics in chronic lymphocytic leukemia: results of an individual patient data-based meta-analysisAxel Benner, Larry Mansouri, Davide Rossi, et al.
Mabs|December 18, 2014
Inhibitors of SRC kinases impair antitumor activity of anti-CD20 monoclonal antibodiesMagdalena Winiarska, Kamil Bojarczuk, Beata Pyrzynska, et al.
Leukemia|March 27, 2019
Short telomeres are associated with inferior outcome, genomic complexity, and clonal evolution in chronic lymphocytic leukemiaBilly Michael Chelliah Jebaraj, Eugen Tausch, Dan A Landau, et al.
Nature Communications|March 10, 2026
Single-cell genomics highlight MYC-associated metabolic activation and altered cell interactions in T-prolymphocytic leukemia progressionLinus Wahnschaffe, Dennis Jungherz, Tony A Müller, et al.
Blood|January 27, 2025
IAP dependency of T-cell prolymphocytic leukemia identified by high-throughput drug screeningMarcel Fabian Pohly, Kerstin Putzker, Sebastian Scheinost, et al.
Haematologica|July 11, 2019
HIF-1α is over-expressed in leukemic cells from <i>TP53</i>-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemiaValentina Griggio, Candida Vitale, Maria Todaro, et al.
Blood|August 13, 2017
Genomic analysis of hairy cell leukemia identifies novel recurrent genetic alterationsBenjamin H Durham, Bartlomiej Getta, Sascha Dietrich, et al.
Nature Genetics|January 19, 2016
DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemiaChristopher C Oakes, Marc Seifert, Yassen Assenov, et al.
Pageof 19